Objective: To assess the association of vaginal commensal and low grade pathogenic bacteria including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Mycoplasma genitalium, Group B Streptococcus (GBS), and Gardnerella vaginalis, in women who delivered preterm at less than 37 weeks gestation in the presence or absence of inflammation of the chorioamnionitic membranes.
Objective
To assess the association of vaginal commensal and low grade pathogenic bacteria including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Mycoplasma genitalium, Group B Streptococcus (GBS), and Gardnerella vaginalis, in women who delivered preterm at less than 37 weeks gestation in the presence or absence of inflammation of the chorioamnionitic membranes.
Methods
A case control study involving women who delivered before 37 weeks gestation with and without inflammation of chorioamnionitic membranes.
A total of 57 placental samples were histologically examined for polymorphonuclear leukocyte infiltration of placental tissue for evidence of chorioamnionitis, and by type-specific nucleic acid amplification for evidence of infection with one or more of the target bacteria.
Demographic data was collected for each mother.
Results
Amongst the 57 placental samples, 42.1% had chorioamnionitis and 24.6% delivered in the second trimester of pregnancy; U. parvum, U. urealyticum, G. vaginalis and GBS were all detected in the study with respective prevalence of 19.3%, 3.5%, 17.5% and 15.8%;
M.genitalium and M. hominis were not detected. U. parvum was significantly associated with chorioamnionitis (p value = 0.02; OR 5.0; (95% CI 1.2-21.5) and was more common in women who delivered in the second (35.7%) compared to the third trimester of pregnancy (13.9%). None of the other bacteria were associated with chorioamnionitis or earlier delivery and all G.vaginalis positive women delivered in the third trimester of pregnancy (p value 0.04). .
Introduction
Preterm delivery is increasing and affects one baby in every 13 born (World Health Organisation, 2013) . Preterm delivery, where a baby is born alive before completion of 37 gestational weeks, accounts for 75% of perinatal mortalities and a significant number of long term neonatal morbidities including chronic lung disease [1, 2] . Intra-amniotic infection is currently a common cause of preterm delivery and is frequently caused by ascending genital tract infection [3, 4] . Following ascent, microbes are capable of eliciting an inflammatory response in the chorioamniotic membrane by initiating an innate immune response resulting in the release of pro-inflammatory cytokines which are thought to trigger early labour [5, 6] .
Inflammation occurring across the chorioamniotic membrane is termed chorioamnionitis and has long been associated with preterm delivery [5, [7] [8] [9] .
Alteration of the vaginal microbiota and pH facilitates the ascent of microbes to the normally sterile amniotic cavity. The altered pH reflects a reduction in the protective lactobacilli species and an overgrowth of anaerobic commensals, including Mycoplasma and Ureaplasma species, a mechanism thought to facilitate ascending infection and adverse sequelae [4] . Ureaplasma and Mycoplasma are Gram negative facultative anaerobic bacteria which frequently colonise the genitourinary tract [10] . While Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma hominis can be regarded as commensal bacteria of the vaginal micro flora, there is supporting evidence they may act as low grade pathogens in pregnancy [11] . Mycoplasma genitalium is recognised as a low-grade urogenital pathogen that has been associated with cervicitis and complications during pregnancy [12] [13] [14] [15] . Gardnerella vaginalis is a common vaginal commensal that is significantly altered in bacterial vaginosis, a microbial disturbance that is known to be linked to preterm labour [16] . Streptococcus agalactiae more commonly known as Group B Streptococcus [GBS], occurs as an intermittent vaginal coloniser present in up to 30% of pregnant women [17] . GBS is associated with early onset neonatal sepsis which has a significantly higher prevalence in preterm pregnancies [17, 18] .
The present study aimed to assess if the detection of any of the 4 genital Mollicutes, G.
vaginalis and/or GBS in placental tissue was associated with the presence of chorionic plate and/or membrane inflammation (chorioamnionitis) in a cohort of women who delivered less than 37 weeks gestation and if their presence was linked with earlier preterm delivery.
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Methods
Inclusion and Exclusion Criteria
Placental specimens from women presenting in labour at the Royal Jubilee Maternity Hospital at <37 weeks gestation were eligible for enrollment and term pregnancies were excluded. In any pregnancy where a shared placenta was present, i.e in monochorionic twins or dichorionic triplets only one placental sample was included. Where twins or triplets did not share a placenta, independent samples for each baby were taken for analysis.
Demographic Data
Forty-nine pregnant women were enrolled into the study. There were 48 white European women and 1 Asian woman recruited. The median age of enrolled women was 29 years (range 18-42 years) with a median gestational age of 29 completed weeks (range 27-31 weeks). There were: 39/49 (79.6%) single pregnancies; 6/49 (12.2%) twin pregnancies and 4/49 (8.2%) triplet pregnancies. Six babies (sample numbers 2, 11, 37, 54, 55 and 64) were excluded from analysis due to sharing a placenta, leaving a total of 57 independent placental samples included in the study. A total of 33 of the 57 (57.9%) were delivered by Caesarean section, with a median birth weight of 1168g (range 890.75g -1598.75g).
Specimen Collection
Placental tissue samples were collected and sampled for later molecular analysis before being sent for histology to the Paediatric Pathology department of the Belfast HSC Trust.
Deep placental tissue as opposed to superficial sampling at the mucosal surface was collected to decrease the risk of accidental bacterial contamination. Tissue samples were collected from the sub-chorionic plate area on the fetal side of the placenta. After lifting off the amnion membrane layer, a section of underlying tissue 1cm 3 was dissected out aseptically and stored in sterile 25ml universal tubes at -70°C prior to nucleic acid extraction.
Histopathology
Each placental sample was subjected to a standard histopathological examination by a Consultant Paediatric Pathologist and categorised for the presence or absence of chorioamnionitis. The Pathologist was blinded to clinical outcomes and acute chorioamnionitis was defined if there were stereotypical patterns of inflammatory changes in chorionic plate or membranes (19) .
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Molecular testing
Nucleic acid extraction
Nucleic acid extracts were prepared using tissue protocol reagents from Qiagen QIAamp kits (Crawley, UK). Individual 20mg tissue samples were cut from stored specimens using sterile scalpel blades. They were homogenised in Buffer ATL (180μl) by bead-beating for 30 seconds in a 2ml micro-centrifuge tube using sterile 3mm tungsten carbide beads. A 20μl volume of Proteinase K was added and the homogenised samples were incubated at 56°C
for 3 hours to completely dissolve the tissue. The resulting lysates were extracted using a standard QIAamp spin column protocol. Total nucleic acid from each specimen was eluted in
Buffer AE (50μl).
Real-time quantitative PCR
Nucleic acid extracts were subjected to 6 real time TaqMan 
Results
Clinical characteristics
Amongst the 57 placentas, 24 (42.1%) and 33 (57.9%) respectively had or did not have histologically confirmed chorioamnionitis. A total of 14 (24.6%) and 43 (75.4%) women delivered respectively in the second and third trimester of pregnancy. Details from histopathology reports for each patient are outlined in table S1.
Molecular Data
Of the 57 placental samples tested, 26 (45.6%) were positive for at least one of the 6 target organisms. The prevalence of organisms respectively detected in the second (n=14) and third (n=43) trimester of pregnancy were for U. parvum -5 (35.7%) and 6 (14%); for U. urealyticum -1 (7.1%) and 1 (2.3%) and for GBS -3 (21.4%) and 6 (14%). All 10 G. vaginalis positive
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samples were detected in the third trimester of pregnancy (23.3%).The comparisons between both trimesters of pregnancy are outlined in Table 2 . The higher prevalence of U.
parvum in women delivering in 2 nd trimester compared to 3 rd trimester approached statistical significance (p=0.07). The opposite association was seen for G. vaginalis where a higher prevalence in women delivering in the third trimester compared to the second trimester reached statistical significance (p=0.04). While GBS and U. urealyticum had higher prevalences in women delivering in the second trimester these did not approach statistical significance (p=0.50 and p=0.40 respectively).
Discussion
While intrauterine infection is regarded as an important cause of preterm delivery [3, 4] the mechanism involved is less clear. The vaginal microbiota is thought to be protective against preterm labour and its disruption, as in bacterial vaginosis, is felt to be a risk factor allowing low pathogenic vaginal bacteria to ascend the genitourinary tract [3, 4] . Infiltration of the chorioamnion by polymorphonuclear leukocytes on histopathological examination was used as a biomarker of inflammation and was confirmed in 24 (42.1%) placentas in the study, suggesting that just over 40% of the preterm births were potentially linked to infection. While detection of U. urealyticum and GBS were more common in placental tissue with inflammation compared to tissue without, the proportions did not reach statistical significance. However, the detection rate of U. parvum in tissue with chorioamnionitis was significantly higher (p=0.02) than the rate detected in tissue without chorioamnionitis suggesting it could have an association with inflammation leading to preterm labour. A larger study should address this association and whether the association was linked to treatable dysbiotic disruption of the vaginal microbiota.
Traditionally U. urealyticum biovars 1 and 2 were regarded as a single species but recently they have been separated into two distinct species, namely U. urealyticum (formerly biovar 2) and U. parvum (formerly biovar 1). This has confounded results in publications prior to the separation [31] . Although previous studies associated U. urealyticum with stillbirth,
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spontaneous abortion, chorioamnionitis and preterm labour [32] , the majority failed to discriminate between both species and used insensitive detection methods [25] [26] [27] [28] .
Therefore clarity is lacking on the respective roles of U. urealyticum and U. parvum in pregnancy [33] . Although genital Mycoplasma, Ureaplasma and other pathogens have been associated with preterm delivery [34, 35] , a high proportion of preterm births have no identifiable cause confirmed [36] . At present, the knowledge base regarding intrauterine infection is inconclusive, in particular the ability of Mycoplasma and Ureaplasma species to induce inflammatory responses in the uterine cavity [27] . Assessing the association of Ureaplasma species with chorioamnionitis in women delivering preterm is important to help assess their role as pathogens in intrauterine infection and preterm delivery [32, 37] . The separate detection of U. urealyticum and U. parvum in clinical specimens from women with and without chorioamnionitis is a prerequisite for this type of study.
Previous studies have reported that inflammatory response induced by U.parvum is frequently associated with preterm delivery [38, 39] . While G. vaginalis and U. parvum have similar colonisation prevalence rates of >50% in the vaginal microbiota of pregnant and nonpregnant women [40, 41] , their recovery in the current study in relation to chorioamnionitis and the gestational age at delivery were inverse. U. parvum showed a strong association with placenta inflammatory infiltration and with delivery in second trimester supporting an association with preterm labour. G. vaginalis showed no association with placenta inflammatory infiltration and was more prevalent at later gestational ages suggesting a nonpathogenic role in preterm labour.
Findings from this study coincide with those reporting a strong association between intrauterine infection and delivery at <30 weeks gestation [36] . Furthermore, a recent study reported a lower preterm delivery rate in pregnant women treated for M. hominis and Ureaplasma species [42] . Those findings and the results of the current study support the need for further research into the pathogenesis of U. parvum associated preterm labour and the potential for its prevention. Interestingly GBS showed no association with inflammatory infiltration of the placenta, and so did not appear to be linked to preterm labour through urogenital inflammation. However like U. parvum it was more common with earlier gestational delivery, suggesting GBS might have a non-inflammatory role in preterm labour. One possible explanation for this might be linked to the recent observation in gravid primates that in-utero infection with GBS can result in the down regulation of multiple cytokeratins and other cytoskeletal genes critical for maintenance of cellular membrane integrity and tensile strength, potentially leading to preterm labour [43] . These changes took place in the absence of inflammation. Additionally GBS has been shown to down-modulate the innate response to J U S T
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infection in the chorioamnion which could again explain the apparent lack of inflammation in the placenta samples tested [44] .
Although relatively small in overall numbers, we believe a real strength of the study was the recruitment of a number of women with extreme preterm pregnancies. From a technical perspective culture-based detection methods often used in the diagnosis of intrauterine infection in women with adverse pregnancy outcomes lack precision and are suboptimal in the identification of the highly fastidious species of the Ureaplasma and Mycoplasma genera.
Thus another main strength of this study was the utilisation of qPCR assays with high analytical sensitivity and specificity to target bacteria that have been previously associated with pregnancy complications and with some that are also common in the vaginal microbiota.
The application of these assays to placental tissue with and without histological evidence of chorioamnionitis, allowed a link to be established with a potential trigger of preterm labour. A perceived weakness in the study design could be exclusion of term pregnancies however since the question addressed was the association with inflammation in preterm delivery and not whether the infections triggered it, the rational controls had to be preterm deliveries lacking histological inflammation of the chorioamniotic membranes. The link seen with U.
parvum and earlier preterm delivery suggests the association would be absent at term and it is probably causal.
The results suggest an association between U. parvum and inflammation of the chorioamniotic membrane in preterm labour; the increased number of positive women with delivery in the second trimester would also suggest an association with preterm delivery.
The mechanism for U. parvum gaining access to the chorioamnion was not addressed.
While a potential association for GBS in preterm delivery was also suggested by the findings, the data did not support a role in placental inflammation. The findings suggest the need for further investigation of the role of U. parvum as a trigger of preterm labour and the findings would support an extension of the present study to include term pregnancies. 
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